Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-04-05

Clinical Trial Update: Study of Erythromycin in GER-Associated Apnea of the Newborn [NA]

View source ↗

Summary

This entry describes a University of Virginia–sponsored clinical trial testing erythromycin for gastroesophageal reflux–associated apnea in newborns; phase and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: University of Virginia | Conditions: Gastroesophageal Reflux, Apnea | NA | Status: UNKNOWN